16 th aseica - tactics.€¦ · 10:45 - 11:00 welcome and introduction dr. carlos camps. hospital...

Venue: Universitat Politècnica de ValènciaEdificio rectorado - Sala ParaninfoCamí de Vera s/n, Valencia

16th ASEICA INTERNATIONAL

CONGRESSValencia, 6th - 7th - 8th November 2018

Organized by:

www.aseica.es

SCIENTIFIC COORDINATORSDr. Carlos Camps

Dr. Arkaitz CarracedoDr. Héctor Peinado

Dra. Angélica FigueroaDra. Noemí ReguartDra. Gema Moreno

SCIENTIFIC COMMITTEEDr. Carlos Camps

Dr. Xosé R. BusteloDra. Noemí Reguart

Dr. Arkaitz CarracedoDr. Jesús Paramio

Dra. Angélica FigueroaDra. Gema MorenoDr. Héctor Peinado

Dra. María S. SoengasDr. José PalaciosDr. Rafael López

Dr. Alberto MúñozDr. Joaquín Arribas

Dra. Anna Bigas

HONOR COMMITTEE

Su Majestad la Reina, Doña Letizia Ortiz

Hble. Sra. Ana Barceló, Consellera de Sanidad Universal

y Salud Pública de Valencia

Don Francisco J. Mora, Rector Magnífico de la Universitat

Politècnica de València

Doña Mª Vicenta Mestre, Rectora Magnífica de

la Universitat de València

Doña Raquel Yotti, Directora Instituto de Salud Carlos III

LOCAL COMMITTEE

Dra. Eloisa Jantus-LewintreDr. Rafael Sirera

Dra. Deborah BurksDra. Silvia Calabuig-Fariñas

08:00 - 10:35 STUDENT WORKSHOP: SKILLS IN INVESTIGATION

08:00 - 08:05 Welcome and Introduction Dra. Eloísa Jantus-Lewintre. Fundación Investigación Hospital General Universitario de Valencia Dra. Ana Blasco. Hospital General Universitario de Valencia

08:05 - 08:25 Bibliometrics and science: importance of indicators in the research career Dra. Rut Lucas. Universitat de València

08:25 - 08:45 What to do after the BSc? Dr. Rafael Sirera. Universitat Politècnica de València

08:45 - 09:05 What comes after the PhD? Dra. Deborah Burks. Centro de Investigación Príncipe Felipe director, Valencia

09:05 - 09:25 How to choose the right mentor Dra. Alba Maiques. CERU representative, London - UK Dr. Juan Rodríguez Vita. CERFA representative, Heideberg - Germany

09:25 - 09:45 Spin off Nanoimmunotech: from research to the company Dra. África González. President of the Spanish Society for Immunology

09:45 - 10:05 Clinical trials in cancer Dr. Vicente Guillem. Instituto Valenciano de Oncología - IVO, Valencia

10:05 - 10:35 Discussion

10:45 - 11:00 WELCOME AND INTRODUCTION Dr. Carlos Camps. Hospital General Universitario de Valencia Dr. Arkaitz Carracedo. CIC bioGUNE, Derio

11:00 - 12:30 KEY SESSION: TUMOR HETEROGENEITY Chairs: Dr. Joaquín Arribas. Vall d’Hebron Institut d’Oncologia-VHIO, Barcelona Dra. Rosa Mª Farràs. Centro de Investigación Príncipe Felipe - CIPF, Valencia

11:00 - 11:20 Breast cancer heterogeneity Dr. Emilio Alba. Hospital Regional Universitario de Málaga y Virgen de la Victoria, Málaga

Valencia, 6th - 7th - 8th November 2018

16th ASEICA INTERNATIONAL CONGRESS

www.aseica.es

TUE

SDA

Y 6

th N

OV

EM

BE

R

3



TUE

SDA

Y 6

th N

OV

EM

BE

R

11:20 - 11:40 Metastasis-initiating cells within tumors Dr. Roger Gomis. Instituto de Investigación Biomédica de Barcelona

11:40 - 12:10 Plenary lecture: Cancer evolution Dr. David Posada. Universidad de Vigo


12:30 - 13:50 JOINT SYMPOSIUM ASEICA - SEI: PRECISION MEDICINE WHEN THERE IS NOT A DRUGGABLE TARGET: IMMUNONCOLOGY

Chairs: Dr. Rafael Sirera. Universitat Politècnica de València Dra. África González. President of the Spanish Society for Immunology

12:30 - 12:50 Novel approaches for NK cell based cancer immunotherapy Dr. Francisco Borrego. Biocruces Bizkaia, Bilbao

12:50 - 13:10 Use of dendritic cells for anti-tumor therapy Dra. Jolanda de Vries. Radboud University, Nijmegen - Netherlands

13:10 - 13:30 TILs and its applicability in cancer Dra. Alena Gros. Vall d’Hebron Institut d’Oncologia - VHIO, Barcelona


13:50 - 15:15 POSTER VIEWING AND LUNCH

15:15 - 16:10 SHORT COMMUNICATIONS · Parallel sessions

TUMOR BIOLOGYChairs: Dr. Francisco X. Real. Centro Nacional de Investigaciones Oncológicas-CNIO, Madrid

Dra. María Abad. Vall d’Hebron Institut d’Oncologia-VHIO, Barcelona

TUMOR TREATMENT Chairs: Dra. Edurne Berra. CIC bioGUNE, Derio

Dr. Bruno Sainz. Universidad Autónoma de Madrid

15:15 - 15:21 Short Communication 1 Short Communication 1



4

TUE

SDA

Y 6

th N

OV

EM

BE

R

16:15 - 17:15 EDUCATIONAL SYMPOSIUM, OPTIMIZING THE TREATMENT IN PROSTATE CANCER

Chairs: Dr. Arkaitz Carracedo. CIC bioGUNE, Derio Dr. Miguel Ángel Climent. Instituto Valenciano de Oncología-IVO, Valencia

16:15 - 16:35 Exploiting paracrine signaling in prostate cancer for therapy Dr. Andrea Alimonti. Institute of Oncology Research, Bellinzona-Switzerland

16:35 - 16:55 The changing care of metastatic prostate cancer treatment Dra. Begoña Mellado. Hospital Clínic de Barcelona


17:15 - 18:15 JOINT SYMPOSIUM ASEICA - SEOM: MILESTONES OF THE TRANSLATIONAL RESEARCH IN ONCOLOGY IN 2018

Chairs: Dr. Xosé R. Bustelo. Centro de Investigación del Cáncer, Universidad de Salamanca-CSIC Dra. Ruth Vera. Complejo Hospitalario de Navarra, Pamplona

17:15 - 17:35 From the clinician’s point of view Dr. Juan Manuel Sepúlveda. Hospital Universitario 12 de Octubre, Madrid

17:35 - 17:55 From the researcher’s point of view Dr. Piero Crespo. Instituto de Biomedicina y Biotecnología de Cantabria - IBBTEC, Santander


18:15 - 19:00 POSTER VIEWING AND COFFEE BREAK

www.aseica.es

5

15:33 - 15:48 Discussant comments Discussant comments




19:00 - 20:25 COOPERATION IN PUBLIC-PRIVATE INNOVATION: NEW TECHNOLOGIES

Chairs: Dr. Enrique Grande. MD Anderson Cancer Center. Madrid Dr. Julián Carretero. Universitat de València

19:00 - 19:20 Polymer therapeutics as anticancer nanomedicines Dra. María J. Vicent. Centro Investigación Príncipe Felipe, Valencia

19:20 - 19:30 PITX2 DNA-methylation, a novel validated marker in high-risk breast cancer Dr. Olaf G. Wilhelm. Therawis Pharma GmbH. Munich, Germany

19:30 - 19:40 Clinical use of Guardant 360 in gastrointestinal tumors Dra. Clara Montagut. Hospital del Mar, Barcelona

19:40 - 19:50 Liquid biopsies as important tool for the implementation of precision oncology. The example of OncoBEAM EGFR mutation assessment in lung cancer Dra. Silvia Calabuig-Fariñas. Fundación Investigación Hospital General Universitario de Valencia

19:50 - 20:00 Study of biomarkers using NGS in liquid biopsy Dra. Atocha Romero. Hospital Universitario Puerta del Hierro Majadahonda, Madrid

20:00 - 20:10 EPICUP, an example of cooperative innovation in PP Dr. Sebastián Morán. Head Dx Development Ferrer


21:00 YOUNG ONCOLOGISTS NETWORKING EVENING (Only for assistents under 45 years old)

Venue: ADEIT | Fundación Universidad-Empresa de la Universidad de Valencia Plaza Virgen de la Paz, 3, 46001 Valencia


TUE

SDA

Y 6

th N

OV

EM

BE

R

6

08:00 - 09:18 PROFFERED AND SHORT COMMUNICATIONS · Parallel sessions

WE

DN

ESD

AY

7th

NO

VE

MB

ER

www.aseica.es

LIQUID BIOPSY AND BIOMARKERS & TUMOR MICROENVIRONMENT Chairs: Dra. Laura Muinelo. Complejo Hospitalario Universitario de Santiago de CompostelaDr. Ernest Nadal. Institut Català d’Oncologia-ICO Hospital Duran i Reynals, Barcelona

TUMOR BIOLOGY & TUMOR TREATMENTChairs: Dra. Verónica Torrano. CIC bioGUNE, DerioDr. Manuel Valiente. Centro Nacional de Investigaciones Oncológicas - CNIO, Madrid

08:00 - 08:10 Proffered Communication 1 Proffered Communication 1








7

09:30 - 10:30 JOINT SYMPOSIUM ASEICA - INTERNATIONAL SOCIETY OF LIQUID BIOPSY ELUCIDATING THE COMPLEXITY OF LIQUID BIOPSIES

Chairs: Dra. Eloisa Jantus-Lewintre. Fundación Investigación Hospital General Universitario de Valencia Dra. María José Serrano. Centro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológica - GENYO

09:30 - 09:50 Exosomes and liquid biopsy Dr. Héctor Peinado. Centro Nacional de Investigaciones Oncológicas - CNIO, Madrid

09:50 - 10:10 cfDNA in liquid biopsy Dra. Ana Vivancos. Vall d’Hebron Institut d’Oncologia - VHIO, Barcelona


10:30 - 11:00 OFFICIAL OPENING



WE

DN

ESD

AY

7th

NO

VE

MB

ER


11:30 - 12:30 EDUCATIONAL SYMPOSIUM, OPTIMIZING THE TREATMENT IN 2019: MECHANISMS OF RESISTANCE TO ONCOGENIC DRIVERS IN LUNG CANCER: FUTURE APPROACHES IN THE LANDSCAPE

Chairs: Dr. Bartomeu Massuti. Instituto de Investigación Sanitaria y Biomédica de Alicante-ISABIAL, Hospital General Universitario de Alicante Dr. Rafael López. Complejo Hospitalario Universitario de Santiago de Compostela

11:30 - 11:50 Facing up novel resistances with irreversible EGFR- kinase inhibitors in lung cancer Dra. Noemí Reguart. Hospital Clínic de Barcelona

11:50 - 12:10 Is there an optimal sequencing approach to overcome resistances in ALK-driven NSCLC tumors? Dra. Enriqueta Felip. Hospital Universitari Vall d’Hebron, Barcelona


12:30 - 14:00 CIBERONC SESSION : CANCER BIOINFORMATICS AND OMICS: BEYOND CANCER GENOMES

12:30 - 12:45 Greetings Dr. Joaquín Arribas. CIBERONC Scientific Director

12:45 - 13:30 Harnessing Big Data to help cancer patients Dr. Xosé M. Fernández, Director of Data, Institut Curie

13:30 - 13:45 Cancer Bioinformatics and Omics CIBERONC Work Module Dr. Víctor Quesada. CIBERONC Work Module Leader

13:45 - 14:00 CANCERTOOL: exploration, visualization and representation of cancer datasets Dra. Verónica Torrano. CIC bioGUNE

8

www.aseica.es


15:30 - 16:30 EDUCATIONAL SYMPOSIUM, OPTIMIZING THE TREATMENT IN 2019: TMB. FRONTIERS IN IMMUNOTHERAPY

Chairs: Dr. Luis Montuenga. Centro de Investigación Médica Aplicada-CIMA. Universidad de Navarra, Pamplona Dr. Óscar Juan-Vidal. Hospital Universitario y Politécnico La Fe, Valencia

15:30 - 15:50 Influences of the neoantigenic load in the response to immunotherapy. Consequences for the development of new drugs. Dr. Luis Paz-Ares. Hospital Universitario 12 de Octubre, Madrid

15:50 - 16:10 Identifying and targeting modulators of immune checkpoint controls in melanoma Dra. María S. Soengas. Centro Nacional de Investigaciones Oncológicas-CNIO, Madrid


16:30 - 18:20 KEY SESSION: NOT ALL ROADS LEAD TO ROME: ONCOGENIC SIGNALING BEYOND THE TUMOR CELL

Chairs: Dr. Rubén Pío. Centro de Investigación Médica Aplicada-CIMA, Universidad de Navarra, Pamplona Dra. María Muñoz Caffarel. Instituto de investigación sanitaria BioDonostia, Donostia

16:30 - 16:50 Aberrant PI3K signaling at the core of vascular malformations or developmental cancer? Dra. Mariona Graupera. Institut d’Investigació Biomèdica de Bellvitge - IDIBELL, Barcelona

16:50 - 17:10 Vascular malformations or development cancer? Dr. Jaume Mora. Hospital Sant Joan de Déu, Barcelona

WE

DN

ESD

AY

7th

NO

VE

MB

ER

9



WE

DN

ESD

AY

7th

NO

VE

MB

ER

17:10 - 17:30 Cancer stem cells as drug target Dr. Guillem Argilés. Hospital Universitari Vall d’Hebron, Barcelona

17:30 - 18:00 Plenary lecture: Targeting the tumour microenvironment to control cancer growth Dra. Kairbaan Hodivala-Dilke. Barts Cancer Institute, London - UK


18:30 - 20:00 ASEICA WOMEN SESSION

Chair: Dra. María S. Soengas. ASEICA women representative

Inspirational Lecture: Yes, we can Sra. Elisa Martin. Chief Technology Officer IBM Spain

Award for the professional development of women in science

21:30 SPEAKERS DINNER

10

www.aseica.es

08:00 - 09:20 YOUNG SESSION CIBER-SEAP-SEBBM: NOVEL APPROACHES IN CANCER RESEARCH

Chairs: Dra. Anna Bigas. Hospital del Mar - Parc de Salut Mar de Barcelona Dr. José Palacios. Hospital Universitario Ramón y Cajal, Madrid Dr. Pedro Lazo-Zbikowski. Centro de Investigación del Cáncer, Universidad de Salamanca - CSIC

08:00 - 08:20 Molecular biophysics and its application to study DNA processing machines involved in DNA break repair Dr. Fernando Moreno. Centro Nacional de Biotecnología, Madrid

08:20 - 08:40 Comparative pathology and molecular characterization of tumors Dra. Mireia Castillo. Chamapalimaud foundation, Lisboa - Portugal

08:40 - 09:00 Secretome & proteomic & microenvironment Dr. Josep Villanueva. Vall d’Hebron Institut d’Oncologia - VHIO, Barcelona


09:20 - 10:50 PRESIDENTIAL SESSION

Chairs: Dr. Carlos Camps. Hospital General Universitario de Valencia Dr. Alfredo Carrato. Hospital Universitario Ramón y Cajal, Madrid

09:20 - 09:50 Plenary lecture: Pi3K from biology to cancer and back Dr. Bart Vanhaesebroek. UCL Cancer Institute, London - UK

09:50 - 10:05 Oral Communication 1




10:50 - 11:40 PRIZES AND BURSARIES


THU

RSD

AY

8th

NO

VE

MB

ER

11



THU

RSD

AY

8th

NO

VE

MB

ER

12

12:25 - 13:15 PLENARY SESSION ASEICA - Fundación Científica AECC-Fundación Bancaria “la Caixa” COMMITTED TO CANCER RESEARCH

Chairs: Dra. Gema Moreno. Universidad Autónoma de Madrid & MD Anderson Cancer Center, Madrid Dra. Angélica Figueroa. Instituto de Investigación Biomédica de A Coruña - INIBIC, A Coruña Dr. Jesús Paramio, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas-CIEMAT, Madrid

12:25 - 12:40 Presentation Dra. Angélica Figueroa. Instituto de Investigación Biomédica de A Coruña - INIBIC, A Coruña

12:40 - 13:15 Discussion Dra. Marta Puyol. Fundación Científica AECC representative Sra. Montserrat Capdevila. Fundación Bancaria “la Caixa” representative Dr. Joaquín Arribas. CIBERONC Scientific director Dr. Joana Paredes. ASPIC Vice-president Dra. Alba Maiques. CERU representative Dr. Juan Rodríguez Vita. CERFA representative

13:15 - 14:15 EDUCATIONAL SYMPOSIUM, OPTIMIZING THE TREATMENT IN 2019: NEW TREATMENT OPTIONS IN CYCLIN INHIBITORS

Chairs: Dr. Alberto Ocaña. Complejo Hospitalario Universitario de Albacete Dr. Agustí Barnadas. Hospital de la Santa Creu i Sant Pau, Barcelona

13:15 - 13:35 Where are they now and where are they headed in the future Dra. Eva Ciruelos, Hospital Universitario 12 de Octubre, Madrid

13:35 - 13:55 The spinning of CDK4/6 inhibitors in Hormone-Positive Breast Cancer Care Dra. Ana Lluch. Hospital Clínico Universitario de Valencia



15:30 - 16:00 ASEICA ASSEMBLY (Only for ASEICA’s members)

www.aseica.es

16:00 - 17:00 CONTROVERSIAL SESSION: PRECLINICAL CANCER MODELS

Chairs: Dr. Alberto Muñoz. Instituto de Investigaciones Biomedicas Alberto Sols IIBM, UAM-CSIC Madrid Dr. Jesús Paramio. Centro de Investigaciones Energéticas, Medioambientals y Tecnológicas-CIEMAT, Madrid

16:00 - 16:20 Transgenic mice as preclinical cancer model Dr. Arkaitz Carracedo. CIC bioGUNE, Derio

16:20 - 16:40 PDX and PDO as preclinical cancer model Dr. Héctor García Palmer. Hospital Universitari Vall d’Hebron, Barcelona


17:00 - 17:30 FAREWELL CONFERENCE: HOW EMBRYOS CAN HELP TO UNDERSTAND CANCER CELL BIOLOGY

Chairs: Dr. Gabriel Capellà. Institut d’Investigació Biòmedica de Bellvitge - IDIBELL, Barcelona Dra. Montserrat Sanchez-Cespedes. Institut d’Investigació Biòmedica de Bellvitge - IDIBELL, Barcelona

17:00 - 17:30 How embryos can help to understand cancer cell biology Dra. Mª Angela Nieto, Instituto de Neurociencias CSIC-UMH, Alicante

17:30 - 17:40 CLOSING

13

THU

RSD

AY

8th

NO

VE

MB

ER

SPONSORED SESSIONS

EDUCATIONAL SYMPOSIUM, OPTIMIZING THE TREATMENT IN 2019:PROSTATE CANCER

EDUCATIONAL SYMPOSIUM, OPTIMIZING THE TREATMENT IN 2019:NEW TREATMENT OPTIONS IN CYCLIN INHIBITORS

EDUCATIONAL SYMPOSIUM, OPTIMIZING THE TREATMENT IN 2019:TMB. FRONTIERS IN IMMUNOTHERAPY

EDUCATIONAL SYMPOSIUM, OPTIMIZING THE TREATMENT IN 2019:MECHANISMS OF RESISTANCE TO ONCOGENIC DRIVERS INLUNG CANCER: FUTURE APPROACHES IN THE LANDSCAPE

JOINT SYMPOSIUM ASEICA - SEOM: MILESTONES OF THE TRANSLATIONAL RESEARCH IN ONCOLOGY IN 2018



SPO

NSO

RE

D S

ESS

ION

S

14

JOINT SYMPOSIUM ASEICA - SEI:PRECISION MEDICINE WHEN THERE IS NOT A DRUGGABLE TARGET: IMMUNONCOLOGY

JOINT SYMPOSIUM ASEICA - INTERNATIONAL SOCIETY OF LIQUID BIOPSY ELUCIDATING THE COMPLEXITY OF LIQUID BIOPSIES

COOPERATION IN PUBLIC-PRIVATE INNOVATION: NEW TECHNOLOGIES

www.aseica.es

15

Partial collaboration

Partial collaboration

SPO

NSO

RE

D S

ESS

ION

S



16

GE

NE

RA

L IN

FOR

MA

TIO

N

VENUEUniversitat Politècnica de ValènciaEdificio Rectorado · Sala Paraninfo. Camí de Vera S/n, Valencia

WEBSITEOn the symposium website you can consult all the information about the symposium: Scientific program, speakers, committees, inscriptions, headquarters, abstracts competition. Also, and once the event is finished, you will find the presentations and photos of it.

LANGUAGESMain languages: English and Spanish

REGISTRATIONOnly proper accredited attendants will be able to access the venue; please, make sure your lanyard is visible all the time. The registration fee covers: access to all the scientific sessions, official documentation, certificate of attendance, coffee breaks and lunches. To register access the inscription form through the symposium website www.aseica.es

CERTIFICATE OF ATTENDANCEIf you wish to receive a certificate of attendance, please fill in the form online;scanning this QR code or through the event website.

ACREDITATIONAccreditation requested to the Spanish System of Continuing Medical Education of the Community of Valencia. Attendance to the entire course is mandatory in order to obtain the accreditation.

Until 30th September

Until 31st October On site

Students and Predocs Members ASEICA-ASPIC-EACR-SEOM-SEOR-SEBBM-SEAP-AECC-CERU-CERFA-CIBERONC-FESEO

150 € 200 € 300 €

Students and Predocs non-members 300 € 350 € 450 €

Members ASEICA-ASPIC-EACR-SEOM-SEOR-SEBBM-SEAP-AECC-CERU-CERFA-CIBERONC-FESEO

275 € 350 € 400 €

Non-members 600 € 650 € 700 €

www.aseica.es

17

NO

TES



18

NO

TES

www.aseica.es

19

NO

TES

PLATINUM

SILVER

BRONZE

COLABORATORS

GOLD

Endorsed by:



16 th aseica - tactics.€¦ · 10:45 - 11:00 welcome and introduction dr. carlos camps. hospital...

Documents